Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tedizolid: a novel oxazolidinone for Gram-positive infections.

× No keyword cloud information.

8 in total

1. In Vitro Activity of Tedizolid Compared to Linezolid and Five Other Antimicrobial Agents against 332 Anaerobic Isolates, Including Bacteroides fragilis Group, Prevotella, Porphyromonas, and Veillonella Species.

Authors: Ellie J C Goldstein; C Vreni Merriam; Diane M Citron
Journal: Antimicrob Agents Chemother Date: 2020-08-20 Impact factor: 5.191

Review 2. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.

Authors: George G Zhanel; Riley Love; Heather Adam; Alyssa Golden; Sheryl Zelenitsky; Frank Schweizer; Bala Gorityala; Philippe R S Lagacé-Wiens; Ethan Rubinstein; Andrew Walkty; Alfred S Gin; Matthew Gilmour; Daryl J Hoban; Joseph P Lynch; James A Karlowsky
Journal: Drugs Date: 2015-02 Impact factor: 9.546

3. In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China.

Authors: D J Biedenbach; S K Bouchillon; B Johnson; J Alder; D F Sahm
Journal: Eur J Clin Microbiol Infect Dis Date: 2016-09-27 Impact factor: 3.267

4. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.

Authors: Ko-Hung Chen; Yu-Tsung Huang; Chun-Hsing Liao; Wang-Hui Sheng; Po-Ren Hsueh
Journal: Antimicrob Agents Chemother Date: 2015-07-27 Impact factor: 5.191

5. In vitro activity of tedizolid against gram-positive bacteria in patients with skin and skin structure infections and hospital-acquired pneumonia: a Korean multicenter study.

Authors: Yangsoon Lee; Sung Kuk Hong; Sunghak Choi; Weonbin Im; Dongeun Yong; Kyungwon Lee
Journal: Ann Lab Med Date: 2015-09 Impact factor: 3.464

Tedizolid: a novel oxazolidinone for Gram-positive infections.

1. In Vitro Activity of Tedizolid Compared to Linezolid and Five Other Antimicrobial Agents against 332 Anaerobic Isolates, Including Bacteroides fragilis Group, Prevotella, Porphyromonas, and Veillonella Species.

Review 2. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.

3. In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China.

4. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.

5. In vitro activity of tedizolid against gram-positive bacteria in patients with skin and skin structure infections and hospital-acquired pneumonia: a Korean multicenter study.

6. New agents approved for treatment of acute staphylococcal skin infections.

Review 7. Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.

8. The asymmetric Henry reaction as synthetic tool for the preparation of the drugs linezolid and rivaroxaban.